Literature DB >> 9127401

Successful radiofrequency catheter ablation of automatic atrial tachycardia with regression of the cardiomyopathy picture.

J A Chiladakis1, V P Vassilikos, T N Maounis, D V Cokkinos, A S Manolis.   

Abstract

Ectopic atrial tachycardia (EAT) is often refractory to pharmacological suppression, and if uncontrolled, it can lead to cardiomyopathy. Although RF current catheter ablation therapy has been effective in eliminating the arrhythmia, there is limited information, particularly in adult patients with regard to the reversal of the tachycardia induced cardiomyopathy. Four adult patients, 20-56 years of age, and a 6-year-old boy, were referred with refractory EAT. Four patients had heart failure and three had depressed LV function by echocardiographic criteria. All patients underwent electrophysiological study, and RF ablation was successful in abolishing the arrhythmogenic foci. Of these, four were located in the right atrium and one in the left atrium, and were identified by recording of the earliest atrial activation. No complications occurred. Termination of the EAT resulted in symptomatic improvement. Serial echocardiographic assessment of LV function indicated a significant reversal of the cardiomyopathy picture with reduction in chamber size and recovery in systolic function; indices of diastolic dysfunction persisted in one patient. Chronic, uncontrolled EAT can cause tachycardia induced cardiomyopathy. The picture of the cardiomyopathy resolves after elimination of the focus. RF ablation is both effective and safe, and may be considered as early therapy, particularly in patients with incessant EAT and ventricular dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9127401     DOI: 10.1111/j.1540-8159.1997.tb05499.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  16 in total

Review 1.  [Cardiology update. I: Electrophysiology].

Authors:  P Weismüller; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-01-15

Review 2.  Mechanisms underlying the development of atrial arrhythmias in heart failure.

Authors:  Vias Markides; Nicholas S Peters
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

3.  Focal atrial tachycardia ablation: Highly successful with conventional mapping.

Authors:  Antonis S Manolis; Kyriakos Lazaridis
Journal:  J Interv Card Electrophysiol       Date:  2018-12-01       Impact factor: 1.900

4.  Resolution of tachycardia-induced cardiomyopathy following ablation of verapamil-sensitive idiopathic left ventricular tachycardia.

Authors:  A Arya; M Haghjoo; P Davari; M A Sadr-Ameli
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

5.  Radiofrequency ablation in pediatric and adult patients: comparative results.

Authors:  A S Manolis; V Vassilikos; T N Maounis; J Chiladakis; D V Cokkinos
Journal:  J Interv Card Electrophysiol       Date:  2001-12       Impact factor: 1.900

6.  Radiofrequency ablation in older children and adolescents by an adult electrophysiology team.

Authors:  A S Manolis; V Vassilikos; T N Maounis; J Chiladakis; D V Cokkinos
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

7.  Outcomes following electroanatomic mapping and ablation for the treatment of ectopic atrial tachycardia in the pediatric population.

Authors:  Rose M Cummings; William T Mahle; Margaret J Strieper; Robert M Campbell; Lynne Costello; Virginia Balfour; Amanda Burchfield; Patricio A Frias
Journal:  Pediatr Cardiol       Date:  2007-11-17       Impact factor: 1.655

Review 8.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12

9.  Ventricular dysfunction: tachycardia induced cardiomyopathy.

Authors:  V Ramesh Iyer
Journal:  Indian Pacing Electrophysiol J       Date:  2008-05-01

Review 10.  The conundrum of ventricular arrhythmia and cardiomyopathy: which abnormality came first?

Authors:  Mishi Bhushan; Samuel J Asirvatham
Journal:  Curr Heart Fail Rep       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.